Literature DB >> 22137466

Electron microscopic demonstration and evaluation of irreversible electroporation-induced nanopores on hepatocyte membranes.

Edward W Lee1, Daphne Wong, Sergey V Prikhodko, Alejandro Perez, Cassidy Tran, Christopher T Loh, Stephen T Kee.   

Abstract

PURPOSE: To demonstrate, evaluate, and verify the existence of irreversible electroporation (IRE)-ablation induced nanopores on the plasma membrane of hepatocytes.
MATERIALS AND METHODS: On animal research committee approval, four New Zealand rabbits and two Yorkshire swine underwent IRE ablation of the liver (90 pulses, 100 μs per pulse at 2,500 V), and selected ablated liver tissues were harvested, fixed, and air-dried according to the electron microscopy (EM) protocol. A scanning electron microscope (SEM; Nova 230 NanoSEM [FEI, Hillsboro, Oregon] with 80 picoamperes and 10-kV acceleration) was used to visualize and verify IRE-created nanopores. Using NIH image (Bethesda, Maryland) and ImageScope (Aperio Inc., Vista, California), 21 ablated tissues (16 rabbit, 5 swine) were evaluated. Corresponding hematoxylin and eosin (H&E) evaluation was performed to verify IRE-induced cell death.
RESULTS: In all 21 IRE-ablated tissues, the SEM was able to show numerous, well-circumscribed, round, and concave-shaped pore defects disturbing the hepatocyte plasma membranes. These pores were not seen in normal liver. The size of the nanopores ranged from 80-490 nm with the greatest frequency of pores in bimodal distribution. The highest frequency of pore size was noted at the size range 340-360 nm.
CONCLUSIONS: IRE induces nanopores on hepatocyte membranes, as shown by SEM. The pore diameters are larger than nanopores created by reversible electroporation (RE), which may have implications for irreversibility or permanency.
Copyright © 2012 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22137466     DOI: 10.1016/j.jvir.2011.09.020

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  33 in total

1.  Use of irreversible electroporation in unresectable pancreatic cancer.

Authors:  Robert C G Martin
Journal:  Hepatobiliary Surg Nutr       Date:  2015-06       Impact factor: 7.293

2.  Rapid dramatic alterations to the tumor microstructure in pancreatic cancer following irreversible electroporation ablation.

Authors:  Zhuoli Zhang; Weiguo Li; Daniel Procissi; Patrick Tyler; Reed A Omary; Andrew C Larson
Journal:  Nanomedicine (Lond)       Date:  2013-09-11       Impact factor: 5.307

Review 3.  Cytoreduction for colorectal metastases: liver, lung, peritoneum, lymph nodes, bone, brain. When does it palliate, prolong survival, and potentially cure?

Authors:  Camille L Stewart; Susanne Warner; Kaori Ito; Mustafa Raoof; Geena X Wu; Jonathan Kessler; Jae Y Kim; Yuman Fong
Journal:  Curr Probl Surg       Date:  2018-10-04       Impact factor: 1.909

4.  Involvement of a Rac1-Dependent Macropinocytosis Pathway in Plasmid DNA Delivery by Electrotransfection.

Authors:  Mao Mao; Liangli Wang; Chun-Chi Chang; Katheryn E Rothenberg; Jianyong Huang; Yingxiao Wang; Brenton D Hoffman; Paloma B Liton; Fan Yuan
Journal:  Mol Ther       Date:  2017-01-24       Impact factor: 11.454

Review 5.  Ablation therapy for hepatocellular carcinoma: past, present and future perspectives.

Authors:  David J Niemeyer; Kerri A Simo; David A Iannitti; Iain H McKillop
Journal:  Hepat Oncol       Date:  2013-12-20

6.  High-voltage pulsed electric field plus photodynamic therapy kills breast cancer cells by triggering apoptosis.

Authors:  Haixia Zhang; Kuangpeng Liu; Zhixiao Xue; Huijuan Yin; Huajiang Dong; Wendong Jin; Xiafei Shi; Han Wang; Hai Wang
Journal:  Am J Transl Res       Date:  2018-02-15       Impact factor: 4.060

7.  Irreversible electroporation for the treatment of localized prostate cancer: a summary of imaging findings and treatment feedback.

Authors:  Matthijs J Scheltema; Arnoud W Postema; Daniel M de Bruin; Mara Buijs; Marc R Engelbrecht; M Pilar Laguna; Hessel Wijkstra; Theo M de Reijke; Jean J M C H de la Rosette
Journal:  Diagn Interv Radiol       Date:  2017 Sep-Oct       Impact factor: 2.630

Review 8.  [Irreversible electroporation. Current value for focal treatment of prostate cancer].

Authors:  J J Wendler; R Ganzer; B Hadaschik; A Blana; T Henkel; K U Köhrmann; S Machtens; A Roosen; G Salomon; L Sentker; U Witzsch; H P Schlemmer; D Baumunk; J Köllermann; M Schostak; U B Liehr
Journal:  Urologe A       Date:  2015-06       Impact factor: 0.639

Review 9.  Irreversible electroporation and the pancreas: What we know and where we are going?

Authors:  Shamar J Young
Journal:  World J Gastrointest Surg       Date:  2015-08-27

Review 10.  Ablative therapies for small renal tumours.

Authors:  Arturo Castro; Lawrence C Jenkins; Nelson Salas; Gideon Lorber; Raymond J Leveillee
Journal:  Nat Rev Urol       Date:  2013-04-23       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.